1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent)
venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a …

WITHDRAWN: Executive Summary - The International Society for Heart and Lung
Transplantation (ISHLT) guidelines for the care of heart transplant recipients - ScienceDirect Skip …

2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …

Background Dabigatran etexilate is a direct oral anticoagulant with potential to overcome the
limitations of standard of care in children with venous thromboembolism. The aims of this …

Central venous catheters (CVC) have revolutionized the care of patients requiring long-term
venous access. With increasing use of CVCs, the incidence of catheter-related thrombosis …

Importance Among patients younger than 21 years of age, the optimal duration of
anticoagulant therapy for venous thromboembolism is unknown. Objective To test the …

Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in
randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard …

Background Patients with single‐ventricle physiology who undergo the Fontan procedure
are at risk for thrombotic events associated with significant morbidity and mortality. The …